You may have guessed that this week I've been focused on issues of science and corruption, particularly with respect to the connection between Big […]
The post BIG PHARMA, CORPSCIENCE INC., AND CORRUPT.GOV appeared first on Giza Death Star.
Health and Human Services Secretary Tom Price speaks outside the White House. (AP/Andrew Harnik)
In the spring before the 2016 presidential election, the Obama administration’s 12-nation trade agreement known as the Trans-Pacific Partnership, or TPP, was still alive. Negotiators worked on details as Congress considered whether to ratify the pact.
On May 18, the California Senate passed a bill that would ban pharmaceutical companies from giving gifts to doctors. The Senate voted 23-13 in favor of sending the bill to the Assembly. [1]
For the bill, SB 790, California lawmakers used a similar 2009 Vermont law enacted in 2009 as a template.
The U.S. Food and Drug Administration (FDA) is tasked with making sure that drugs and medical devices are safe and efficient for Americans to use. However, it appears that the agency doesn’t take its job seriously enough, because a new study shows that nearly 1/3 of medications approved from 2001 to 2010 had safety issues years after they were made widely available to patients, and some were quite serious. [1]
The U.S. Food and Drug Administration (FDA) confirms the popular Johnson & Johnson (J&J) diabetes drug Invokana (Invokamet, Invokamet XR) increases the risk of foot and leg amputations in people with Type 2 diabetes. [1]
The results of 2 clinical trials showed leg and foot amputations occurred about twice as often in patients taking Invokana (generic name: canagliflozin) as those given a placebo, according to an announcement on the FDA’s website. [2]
Whether you’re a celebrity or factory worker, much-loved or infamous, Alzheimer’s disease doesn’t care who you are. Like a mindless monster, it eats everything that makes people who they are. But even though you can’t reason with it, an increasing number of nutritional and herbal medicines are showing potential in the fight against Alzheimer’s disease (AD). Now, researchers are finding a connection between turmeric and Alzheimer’s prevention, focusing on a increasingly popular herbal solution.
New research shows a 43% increase in clinical trials funded by drug companies during 2006-2014. Can you say “conflict of interest?”
Concerns have been expressed over the past few years about the independence of clinical trials, due to the funding of some trials by corporations with vested interests. New data from Johns Hopkins University suggests that this is now the norm rather than the exception. The clinical trials that allow a drug to go to market are most often funded by the pharmaceutical industry.
Many adverse side effects and even deaths are occurring due to medical negligence. Specifically, this is due to the irresponsibility of scientists who are not reporting the results of their clinical trials to the public, as required by a 2007 law.
According to a study published in the New England Journal of Medicine, the public access website clinicaltrials.gov draws 57,000 visitors a day, including people who are confronting serious diseases and seeking help to treat them with experimental drugs.
